Patent Term Extension Application for DEFENCATH® (taurolidine and heparin), Patent No. 7,696,182 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2024-E-4132

Patent Term Extension Application for DEFENCATH® (taurolidine and heparin), Patent No. 7,696,182

Documents

Comments

Description

Open

Comment Period OpensSep 4, 2024

Type	Title	Posted	Comments	Status
Other	Requirement for Information Pursuant to 37 CFR 1.750 from U.S Patent and Trademark Office to Offit Kurman	Mar 25, 2026	--

CDER

Patent Term Extension Application

Patent No. 7,696,182

DEFENCATH® (taurolidine and heparin)

ND Partners, LLC

CorMedix Inc.

One Liberty Place

Open